Literature DB >> 8679204

Optimization of competitor poly(dI-dC).poly(dI-dC) levels is advised in DNA-protein interaction studies involving enriched nuclear proteins.

K Larouche1, M J Bergeron, S Leclerc, S L Guérin.   

Abstract

Procedures used for investigating DNA-protein interactions, such as the electrophoretic mobility shift assay (EMSA) or DNasel footprinting, require that exogenous nucleic acids (or synthetic equivalents) be added to the reaction mixture to prevent or reduce the nonspecific interaction of nuclear proteins with the labeled probe of choice, especially when proteins are obtained from crude nuclear extracts. One of the most potent, and likely the most widely used, non-specific competitor is the synthetic polymer poly(dI-dC).poly(dI-dC). Its addition to the reaction mixture prior to crude nuclear proteins has unquestionably proven very efficient in reducing nonspecific interactions by facilitating detection of the complexes of interest. However, in certain instances, the use of crude extracts alone does not provide adequate answers and the need to further enrich such extracts becomes absolutely necessary. In this study, we provide evidence that amounts of poly(dI-dC).poly(dI-dC) well below those currently described in the literature substantially impair, or even totally prevent, the detection of specific DNA-protein complexes in EMSA when enriched, gel-fractionated or commercially purified nuclear proteins are used, therefore indicating the need to precisely optimize the amount of such a competitor in DNA-protein interaction studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679204     DOI: 10.2144/19962003439

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  9 in total

1.  Recruitment of the ParG segregation protein to different affinity DNA sites.

Authors:  Massimiliano Zampini; Andrew Derome; Simon E S Bailey; Daniela Barillà; Finbarr Hayes
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

2.  T(3): targeted proteomics of DNA-binding proteins.

Authors:  Linda I Nagore; Harry W Jarrett
Journal:  Anal Biochem       Date:  2015-01-31       Impact factor: 3.365

3.  Molecular Cloning, Purification and Characterization of Mce1R of Mycobacterium tuberculosis.

Authors:  Dipanwita Maity; Rajasekhara Reddy Katreddy; Amitava Bandhu
Journal:  Mol Biotechnol       Date:  2021-01-09       Impact factor: 2.695

4.  An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides.

Authors:  Yi-Wen Hsieh; Amel Alqadah; Chiou-Fen Chuang
Journal:  J Vis Exp       Date:  2016-11-29       Impact factor: 1.355

Review 5.  Pioneer factors and their in vitro identification methods.

Authors:  Xinyang Yu; Michael J Buck
Journal:  Mol Genet Genomics       Date:  2020-04-15       Impact factor: 3.291

6.  PU.1 is involved in the immune response to Aspergillus fumigatus through upregulating Dectin-1 expression.

Authors:  Min Wang; Zhicheng Liu; Chenyang Liu; Ting Wu; Feng Cai; Quan Wang; Xin Su; Yi Shi
Journal:  BMC Infect Dis       Date:  2016-06-16       Impact factor: 3.090

7.  Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3.

Authors:  Samuel J Cutler; James D Doecke; Ibtisam Ghazawi; Jinbo Yang; Lyn R Griffiths; Kevin J Spring; Stephen J Ralph; Albert S Mellick
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

8.  The long zinc finger domain of PRDM9 forms a highly stable and long-lived complex with its DNA recognition sequence.

Authors:  Yasmin Striedner; Theresa Schwarz; Thomas Welte; Andreas Futschik; Ulrich Rant; Irene Tiemann-Boege
Journal:  Chromosome Res       Date:  2017-02-02       Impact factor: 5.239

9.  Inhibition of N-terminal lysines acetylation and transcription factor assembly by epirubicin induced deranged cell homeostasis.

Authors:  Shahper N Khan; Mohd Danishuddin; Bhavna Varshney; Sunil K Lal; Asad U Khan
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.